4D Molecular Therapeutics, Inc.
Ticker: 1650648
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 3.05+3288.9% | 0.09+350.0% | 0.02+100.0% | 0.01 | 0.00-100.0% | 0.01-66.7% | 0.03-99.9% | 20.20 |
| Total Income | 3.05+3288.9% | 0.09+350.0% | 0.02+100.0% | 0.01 | 0.00-100.0% | 0.01-66.7% | 0.03-99.9% | 20.20 |
| EXPENSES | ||||||||
| Expenditure | 76.67+25.1% | 61.28+3.0% | 59.47+10.9% | 53.64+4.9% | 51.14+20.4% | 42.46+11.3% | 38.16+11.6% | 34.18 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| PROFIT | ||||||||
| Net Profit | -68.76-20.9% | -56.88-4.1% | -54.66-13.9% | -47.97-9.4% | -43.84-25.4% | -34.95-7.9% | -32.40-215.8% | -10.26 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-30.83pp | -69.17% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-49.24pp | -50.76% |
| EPS | -1.01+0.0% | -1.01-3.1% | -0.98-14.0% | -0.86-8.9% | -0.79-25.4% | -0.63+4.5% | -0.66-175.0% | -0.24 |
Corporate Events
Board MeetingFDMT
202617Jun
Board Meeting
Annual Meeting of Stockholders to elect Class III directors,…
SEC Filing ↗